These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15779349)

  • 1. [The prevalence of impaired glucose tolerance in life-style related disease].
    Tomono S; Utsugi T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():78-81. PubMed ID: 15779349
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular risk factors in the Lublin Region population with and without type-2 diabetes mellitus.
    Mardarowicz G; Lopatyński J; Szcześniak G
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):471-7. PubMed ID: 15323239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
    Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment for hypertension with metabolic disorders (DM etc)].
    Shimamoto K; Miura T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():513-9. PubMed ID: 16981585
    [No Abstract]   [Full Text] [Related]  

  • 5. [Risk factors for ischemic heart disease in young adults].
    Kobayashi T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():753-6. PubMed ID: 12735061
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
    Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The internal and external cohort studies about impaired glucose tolerance].
    Shibazaki S; Nagai M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():82-6. PubMed ID: 15779350
    [No Abstract]   [Full Text] [Related]  

  • 8. [Impaired glucose tolerance in the elderly--prevalence, pathogenesis and management].
    Ito H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():341-4. PubMed ID: 15779400
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tanno-Sobetsu chou study].
    Shimamoto K; Miura T; Saito S
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():104-7. PubMed ID: 16981528
    [No Abstract]   [Full Text] [Related]  

  • 10. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type II Diabetes Mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors.
    Al-Habori M; Al-Mamari M; Al-Meeri A
    Diabetes Res Clin Pract; 2004 Sep; 65(3):275-81. PubMed ID: 15331208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albuminuria in Australian Aboriginal people: prevalence and associations with components of the metabolic syndrome.
    Rowley KG; Iser DM; Best JD; O'Dea K; Leonard D; McDermott R
    Diabetologia; 2000 Nov; 43(11):1397-403. PubMed ID: 11126409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of metabolic syndrome according to combinations of lifestyle factors among middle-aged Japanese male workers.
    Li Y; Yatsuya H; Iso H; Tamakoshi K; Toyoshima H
    Prev Med; 2010 Aug; 51(2):118-22. PubMed ID: 20451548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired glucose tolerance: obesity and inactivity as modifiable risk factors.
    Taylor K
    Adv Nurse Pract; 2001 Dec; 9(12):59-61. PubMed ID: 12400355
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and determinants of diabetes and impaired fasting glucose among urban community-dwelling adults in Guangzhou, China.
    Wang H; Qiu Q; Tan LL; Liu T; Deng XQ; Chen YM; Chen W; Yu XQ; Hu BJ; Chen WQ
    Diabetes Metab; 2009 Nov; 35(5):378-84. PubMed ID: 19665414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Major nutrition-related risk factors of ischemic heart disease: dyslipoproteinemia, obesity, hypertension, glucose intolerance].
    Pados G
    Orv Hetil; 1999 Jul; 140(28):1563-72. PubMed ID: 10443132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of knee osteoarthritis with the accumulation of metabolic risk factors such as overweight, hypertension, dyslipidemia, and impaired glucose tolerance in Japanese men and women: the ROAD study.
    Yoshimura N; Muraki S; Oka H; Kawaguchi H; Nakamura K; Akune T
    J Rheumatol; 2011 May; 38(5):921-30. PubMed ID: 21324967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and respiratory comorbidities of childhood obesity.
    Fennoy I
    Pediatr Ann; 2010 Mar; 39(3):140-6. PubMed ID: 20302245
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome.
    Mohan V; Farooq S; Deepa M; Ravikumar R; Pitchumoni CS
    Diabetes Res Clin Pract; 2009 Apr; 84(1):84-91. PubMed ID: 19168251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors--the Chennai Urban Population Study (CUPS 14).
    Mohan V; Shanthirani CS; Deepa R
    J Assoc Physicians India; 2003 Aug; 51():771-7. PubMed ID: 14651136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.